Valeant confirms $1bn deal for ‘female viagra’ creator Sprout
August 20, 2015Manufacturing and Production, Sales and Marketing Addyi, Sprout, Sprout Pharma, Sprout Pharmaceuticals, Valeant, flibanserin
Canada’s Valeant Pharmaceuticals has confirmed it will pay $1 billion to acquire Sprout Pharmaceuticals, the company behind the female libido …
Lundbeck sheds 1,000 jobs in £284 million restructure
August 20, 2015Manufacturing and Production, Sales and Marketing Lundbeck, generics, job losses, patents, redundancies, restructure, restructuring
Lundbeck is cutting a thousand jobs globally as part of a restructuring programme to significantly lower its cost and focus …
Amgen agrees to $71m settlement over false advertising
August 19, 2015Sales and Marketing Amgen, Aranesp, Enbrel
Amgen has reached a $71 million settlement with 48 US states and the District of Columbia, to resolve allegations that …
FDA approves ‘female viagra’
August 19, 2015Research and Development, Sales and Marketing Addyi, FDA, HSDD, Sprout, Sprout Pharmaceuticals, flibanserin, hypoactive sexual desire disorder
The FDA has approved Sprout Pharmaceuticals’ Addyi, a controversial libido-enhancing drug for women that has been dubbed the ‘female viagra’. …
Nottingham receives go ahead for new £30m life science facility
August 19, 2015Manufacturing and Production, Research and Development BioCity Nottingham, R&D
Hundreds of pharma jobs are expected to be created in Nottingham after the construction of a new £30 million life …
Confronting the ‘danger’ of blocking progress on clinical trial transparency
August 19, 2015Research and Development EMIG, Ethical Medicines Industry Group, Richmond Pharmacology, clinical trial registration, clinical trial transparency, health research authority, hra, sense about science, transparency
The Ethical Medicines Industry Group and Sense About Science – a co-founder of the ALLTrials campaign – have written a …
HRA must continue ‘progress towards clinical trial transparency’
August 19, 2015Research and Development EMIG, Ethical Medicines Industry Group, Richmond Pharmacology, clinical trial registration, clinical trial transparency, health research authority, hra, sense about science, transparency
Campaigners and industry leaders have urged the Health Research Authority to ensure that its work to bring about full transparency …
Kite Pharma says trial death was unrelated to KTE-C19
August 18, 2015Medical Communications, Research and Development CAR-T, cinical trials, kite pharma, non-Hodgkin's lymphoma, non-Hodgkin’s lymphoma
Kite has confirmed last week’s rumours that a patient had died during its Phase I/II trial for the KTE-C19 non-Hodgkin’s …
Biogen collaborates with ALSA and Columbia University on genomic-based ALS treatments
August 18, 2015Research and Development
Biogen, the ALS Association and Columbia University Medical Center (CUMC) have announced a new collaboration aimed at better understanding the differences …
Birmingham opens BioHub for life science start-ups
August 18, 2015Manufacturing and Production Birmingham, Diagnostics, hubs, life sciences, research hubs, start-ups
A £7 million biomedical laboratory has opened in Birmingham to attract life-science researchers and start-ups. The BioHub is a new …
New NICE guidelines to tackle antibiotic ‘addiction’
August 18, 2015Manufacturing and Production AMR, Antibiotics, NICE, antimicrobial resistance, guidance, infections
NICE has published guidance to help health care professionals promote and monitor the sensible use of antibiotics – and support …
Roche lung cancer therapy succeeds in mid-stage trial
August 17, 2015Research and Development, Sales and Marketing Genentech, Roche, atezolizumab, lung cancer, non-small cell lung cancer
Roche’s biotech arm Genentech has scored positive results in a pivotal Phase II study of its investigational cancer immunotherapy atezolizumab. …
FDA approves limited OxyContin use in children
August 17, 2015Sales and Marketing FDA, OxyContin, Purdue, Purdue Pharma, oxycodone
The FDA has approved the limited use of the strong painkiller Oxycontin for children in the US aged between 11 …
Google to expand diabetes monitoring technology
August 14, 2015Medical Communications blood sugar, diabetes, glucose, google, smart technology, wearable tech
Google is teaming up with the diabetes device maker DexCom to build a small and affordable sensor that could help …
Tamzin Redston joines Wave
August 14, 2015Medical Communications Tamzin Redston, Wave communications
Tamzin Redston has been appointed programme director at Wave, the specialist medical education company.Tamzin joins Wave with a background of …
Merck in immuno-oncology collaboration with major cancer research centre
August 14, 2015Research and Development Cancer, Merck, keytruda, oncology
Merck is teaming up with the University of Texas to evaluate Merck’s anti-PD-1 therapy, Keytruda, in combination with other treatmentsA team …
GSK closes Legionella-hit US site
August 14, 2015Manufacturing and Production GSK, Legionnaire's disease, legionella, manufacturing, production
GSK has temporarily shut down its manufacturing site in North Carolina due to the discovery of the bacteria which causes …
Bayer’s complaint over ‘misleading’ Novartis eye drug claims upheld
August 14, 2015Medical Communications Bayer, Eylea, Lucentis, Novartis, PMCPA, code of conduct
The industry’s code of conduct regulator has ruled in favour of Bayer in a dispute claims made by Novartis when …
Pfizer offers to pay for UK Lyrica switches
August 13, 2015Lyrica, NHS England, Pfizer, generics, neuropathic pain, patents, pregabalin
Pfizer is to pay the administrative costs of GPs to switch patients to Lyrica from generic versions of pregabalin, as …
Abbvie and Roche report success in Phase II leukaemia trial
August 13, 2015Research and Development AbbVie, Breakthrough Therapy Designation, CLL, EMA, FDA, Roche, chronic lymphocytic leukaemia, leukaemia, venetoclax
AbbVie plans to submit regulatory applications for its leukaemia drug venetoclax to the FDA and the EMA before the end …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
